Saturday 17 October 2026
Export TEM’s income statement to Excel — free account
Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024. In the quarter to June 2026, revenue grew 21.6%, EPS grew 112.0%, free cash flow fell 153.7% and total debt rose 70.5%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three.
64.72
6.41
−9.01%
Follow TEM
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 5 | 4 | — |
+8 more TTM periods Free account |
| (67.44%) | (81.58%) | (89.48%) | (72.61%) | ||
| (12.75%) | (16.47%) | (15.31%) | (12.53%) | ||
ROIC |
(17.87%) | (16.63%) | (16.20%) | (15.23%) | |
Return on Tangible Assets |
(25.74%) | (36.74%) | (27.72%) | (22.98%) | |
Average Days of Receivables |
91.99 | 82.57 | 89.31 | 93.66 | |
Free Cash Flow per Share |
(1.52) | (1.23) | (1.41) | (1.43) | |
Free Cash Flow |
(272.97) | (219.70) | (245.35) | (249.44) | |
Capital Expenditures |
(35.54) | (33.96) | (27.26) | (28.89) | |
| Other line items | |||||
Cash ROIC |
(10.41%) | (9.60%) | (9.87%) | (9.93%) | |
Accounts Receivable Turnover |
4.57 | 4.78 | 5.46 | 5.15 | |
Accounts Payable Turnover |
6.74 | 7.70 | 6.98 | 7.79 | |
Inventory Turnover |
10.20 | 9.76 | 10.52 | 9.29 | |
Average Days of Payables |
52.23 | 29.98 | 63.15 | 51.39 | |
Days of Inventory on Hand |
37.87 | 37.88 | 39.84 | 47.44 | |
Tax Rate |
(0.02) | (0.02) | (0.18) | (0.19) | |
Research and Development Expense of Revenue |
25.45% | 25.21% | 25.09% | 26.23% | |
Selling, General and Administrative Expense of Revenue |
58.30% | 57.89% | 57.54% | 57.41% | |
Share Based Compensation of Revenue |
13.00% | 11.32% | 9.81% | 9.43% | |
Interest Coverage |
(5.12) | (4.04) | (3.60) | (3.54) | |
Operating CF/Net income |
0.93 | 0.61 | 0.89 | 1.08 | |
Depreciation/Fixed assets |
1.26 | 1.28 | 1.20 | 0.99 | |
Capex/Depreciation |
(0.32) | (0.30) | (0.26) | (0.32) | |
Revenue per Share |
7.96 | 7.63 | 7.30 | 6.32 | |
Operating CF per Share |
(1.32) | (1.04) | (1.25) | (1.26) | |
Capex per Share |
(0.20) | (0.19) | (0.16) | (0.17) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.03 |
Columns are period end dates